418 related articles for article (PubMed ID: 34772357)
1. Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC.
Li J; Yan T; Wu X; Ke X; Li X; Zhu Y; Yang J; Li Z
BMC Cancer; 2021 Nov; 21(1):1205. PubMed ID: 34772357
[TBL] [Abstract][Full Text] [Related]
2. FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis.
Huang J; Liang B; Wang T
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34269372
[TBL] [Abstract][Full Text] [Related]
3. Foxhead box D1 promotes the partial epithelial-to-mesenchymal transition of laryngeal squamous cell carcinoma cells via transcriptionally activating the expression of zinc finger protein 532.
Fan L; Wang J; Deng P; Wang Y; Zhang A; Yang M; Zeng G
Bioengineered; 2022 Feb; 13(2):3057-3069. PubMed ID: 35112956
[TBL] [Abstract][Full Text] [Related]
4. FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma.
Liang H; Zhang C; Li C; Li C; Wang Y; Lin H
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34028536
[TBL] [Abstract][Full Text] [Related]
5. ETV5 facilitates tumor progression in head-neck squamous cell carcinoma.
Yu S; Ma Z; Chen T; Wang H; Yao Q; Li J; Cheng J
Oral Dis; 2024 May; 30(4):2004-2017. PubMed ID: 37649213
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
7. RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers.
Lin D; Lin B; Bhanot H; Riou R; Abt NB; Rajagopal J; Saladi SV
Oral Oncol; 2020 Dec; 111():104930. PubMed ID: 32745900
[TBL] [Abstract][Full Text] [Related]
8. ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β-catenin pathway.
Wang R; Liu X; Li X; Qian M; Yang X; Jiang Q; Wang Y; Liu H; Chen J; Wang X; Gong L
Mol Carcinog; 2024 Jun; 63(6):1079-1091. PubMed ID: 38426809
[TBL] [Abstract][Full Text] [Related]
9. MMP1 Overexpression Promotes Cancer Progression and Associates with Poor Outcome in Head and Neck Carcinoma.
Zhang W; Huang X; Huang R; Zhu H; Ye P; Lin X; Zhang S; Wu M; Jiang F
Comput Math Methods Med; 2022; 2022():3058342. PubMed ID: 36105241
[TBL] [Abstract][Full Text] [Related]
10. Identification of Antitumor
Minemura C; Asai S; Koma A; Kikkawa N; Kato M; Kasamatsu A; Uzawa K; Hanazawa T; Seki N
Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886008
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of FOXD1 is associated with cervical node metastasis and unfavorable prognosis in oral squamous cell carcinoma.
Li Z; Yan T; Wu X; Zhang W; Li J; Wang L; Yang J
J Oral Pathol Med; 2020 Nov; 49(10):1030-1036. PubMed ID: 32808339
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of lncRNA WWTR1-AS1 associates with tumor aggressiveness and unfavorable survival in head-neck squamous cell carcinoma.
Li J; Li Z; Wu Y; Diao P; Zhang W; Wang Y; Yang J; Cheng J
J Cell Biochem; 2019 Oct; 120(10):18266-18277. PubMed ID: 31172583
[TBL] [Abstract][Full Text] [Related]
13. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma.
Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma.
Wu Y; Diao P; Li Z; Zhang W; Wang D; Wang Y; Cheng J
J Oral Pathol Med; 2018 May; 47(5):502-510. PubMed ID: 29569374
[TBL] [Abstract][Full Text] [Related]
15. FOXD1 Promotes Cell Growth and Metastasis by Activation of Vimentin in NSCLC.
Li D; Fan S; Yu F; Zhu X; Song Y; Ye M; Fan L; Lv Z
Cell Physiol Biochem; 2018; 51(6):2716-2731. PubMed ID: 30562753
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA LINC01296 acts as a migration and invasion promoter in head and neck squamous cell carcinoma and predicts poor prognosis.
Wu J; Chen H; Li J; Li X; Cao J; Qi M
Bioengineered; 2021 Dec; 12(1):5607-5619. PubMed ID: 34515611
[TBL] [Abstract][Full Text] [Related]
17. miR-17-5p drives G2/M-phase accumulation by directly targeting CCNG2 and is related to recurrence of head and neck squamous cell carcinoma.
Huang Q; Shen YJ; Hsueh CY; Guo Y; Zhang YF; Li JY; Zhou L
BMC Cancer; 2021 Oct; 21(1):1074. PubMed ID: 34598688
[TBL] [Abstract][Full Text] [Related]
18. FOXD1 Regulates the Sensitivity of Cetuximab by Regulating the Expression of EGFR in Head and Neck Squamous Cell Cancer.
Mu L; Zhang J; Wu Z; Huang J; Cui Y
J Healthc Eng; 2022; 2022():6108241. PubMed ID: 35126932
[TBL] [Abstract][Full Text] [Related]
19. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance and biological functions of chemokine CXCL3 in head and neck squamous cell carcinoma.
Guan J; Weng J; Ren Q; Zhang C; Hu L; Deng W; Lu S; Dong X; Li W; Li Y; Wang W
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34870709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]